CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Grunenthal Pharma GmbH & Co. KG is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Grunenthal Pharma GmbH & Co. KG
Zieglerstrabe 6
Phone: +49 241 569-0p:+49 241 569-0 Aachen, 52078  Germany

Business Summary
Grunenthal Pharma GmbH & Co. KG operates as a family-owned pharmaceutical company focused on pain therapies. The Company is a large seller of centrally acting analgesics, which are compounds that inhibit pain by acting on the central nervous system.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
---YesYesYes-

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
--Yes----

Subsidiaries
Business Name Address City State/Province Country
Grunenthal GmbH Zieglerstr. 6 Aachen Germany
The Grunenthal GmbH Arne Jacobsens All 7 Kbenhavn S DK
Laboratorios Andromaco S.A. Av. Quilin 5273 Penalolen Chile
Thar Pharmaceuticals Inc 150 Gamma Dr PITTSBURGH PA United States

Business Names
Business Name
Grunenthal GmbH
Laboratorios Andromaco S.A.
Thar Pharmaceuticals Inc


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 5, 2024